Please Wait...

Tanja Schubert

You are here

Main profile

Tanja Schubert, PhD
Tanja Schubert, PhD
VP & General Manager, Bioclinica Lab

Dr. Tanja Schubert, PhD, is Vice President and General Manager of Biochemical Markers at Bioclinica Lab. She leads the Molecular Marker Lab division of the company and is responsible for all operational activities, including lab processes, service quality, study management, process improvements and regulatory compliance.  She holds the accreditation of the College of American Pathologists for Bioclinica Lab and is a trained Pharmacist, with a PhD in Natural Sciences from Ludwig-Maximilians-Universität München, Germany.


CSF biomarkers & Alzheimer's Disease

The Use of CSF Biomarkers in Alzheimer's Clinical Trials

The Importance of Early Diagnosis for AD Last month, scientists, clinicians, drug sponsors, and regulators gathered in our nation's capital at the annual Alzheimer's Association International Conference (AAIC) to share recent advances in AD research and clinical drug development.


Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Our #Alzheimers expert's work will B showcased at #ADPD2017 Preview here @adpdnet
bioclinica (Yesterday)
#FunFriday ! A long time ago in a lab far far away....
bioclinica (Yesterday)
Smiles all around on Pizza Day today for @bioclinica eHealth in Audubon compliments of our CTO Andrew Masters. This…
bioclinica (2 days ago)
Missed Tuesday's webinar on agile #IRT? No worries! Catch it here > #Pharma #CRO #eClinical
bioclinica (2 days ago)
RT @ACROhealth: Where do you stand on regulating #mHealth & #Wearables in #clinicalresearch? w/ @bioclinica, @ICONplc, @INC_Research https:…
bioclinica (4 days ago)
RT @ACROhealth: ICYMI: @CCTAwareness’ Infographic on #clinicaltrials awareness for #Alzheimer’s and Parkinson’s treatments.…
bioclinica (4 days ago)

Latest Blogs: